Loading candles…
OneSource Specialty Pharma Ltd, incorporated in 2007, operates in the pharmaceutical, biologics, and contract development and manufacturing sectors. The company specializes in the research, development, manufacture, and commercialization of biological drug products presented in various injectable formats. It provides comprehensive contract development and manufacturing organization (CDMO) services covering all phases of pre-clinical and clinical development, as well as commercial supply of biologics and other pharmaceutical products. Formed through the consolidation of the softgel business of Strides Pharma Science, the sterile injectables business of SteriScience, and the biopharma business of Stelis Biopharma, OneSource is a multimodal pure-play specialty pharmaceutical CDMO. Its offerings span advanced technology platforms and therapeutic modalities, including biologics, drug-device combinations, sterile injectables, and oral technologies.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 13 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 23 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 4 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 5 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.